Swedbank’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NBIX
Swedbank's NBIX Position: Q3 2026 in Review
Swedbank increased its Neurocrine Biosciences (NBIX) stake by 16% in Q3 2026, buying an estimated $16.6M and bringing the position to 754,282 shares worth $107M. The position accounts for 0.09% of the portfolio, ranked #157.
Swedbank first reported a position in NBIX in Q1 2021 and has held it in 23 quarters since. The position peaked at $110M in Q2 2026. 773 funds tracked by Wall St. Rank hold NBIX as of Q3 2026.
- Swedbank held 754,282 shares of Neurocrine Biosciences worth $107M as of Q3 2026.
- Swedbank bought 103,200 Neurocrine Biosciences shares in Q3 2026, an estimated $16.6M.
- Neurocrine Biosciences made up 0.09% of Swedbank's portfolio in Q3 2026, its #157 holding.
- Swedbank first reported a position in Neurocrine Biosciences in Q1 2021 and has held it in 23 quarters since.
- Swedbank's Neurocrine Biosciences position peaked at $110M in Q2 2026.
- 773 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2026.
Based on Swedbank's 13F filing for Q3 2026, filed 27 Oct 2026.